Case report
A 25-year-old female with a past medical history of sickle cell anemia and endocarditis was admitted to the hospital for evaluation of persistent fever. Echocardiography done to rule out vegetations incidentally revealed severe aortic insufficiency. Cardiothoracic surgery was consulted and aortic valve replacement surgery was offered. The patient declined any intervention at this time. A diagnosis of tonsillar abscess was made and she was discharged home with appropriate antibiotics.
The patient presented to the hospital a year later with worsening dyspnea. Echocardiogram revealed severe aortic insufficiency (AI), moderate mitral regurgitation (MR) and moderate to severe tricuspid regurgitation (TR) with normal left ventricle (LV) function. Physical examination demonstrated a well-nourished female in no apparent distress at rest but having dizziness and shortness of breath on exertion. A IIIyVI systolic murmur was present on auscultation. Electrocardiogram showed sinus rhythm with ST and T wave abnormalities. Cardiothoracic surgery was consulted and aortic valve replacement surgery was planned. The patient received a preoperative exchange transfusion. Pre-and post-exchange transfusion hemoglobin (Hb) levels are shown in Table 1 .
The patient was brought to the operating room in stable condition. Partial sternotomy was performed and taken down to the pericardium and heart was exposed. The patient was heparinized. Cannulation was performed in the left groin using Edwards 20 fr cannula for the common femoral artery and Cardiovations 19 fr cannula for the common femoral vein, and patient was placed on cardio- pulmonary bypass (CPB). Patient was kept normo-thermic. Using self-inflating coronary artery ostial cannulas oxygenated blood was continuously perfused into the left and right coronary ostia. A flexible aortic clamp was placed on the distal ascending aorta. An incision was created in the ascending aorta and the valve was identified and excised. The 21 mm valve sizer fitted satisfactorily in the annulus. A 21-mm medtronic mosaic porcine heart valve was placed into the aortic annulus using 2-0 Tevedek interrupted sutures with pledgets. The aorta was then closed using 4-0 Prolene in a running fashion with pledgets at each corner. The coronary cannulas were removed as the last aortic closure suture was placed. Throughout the cross-clamp the heart continued in sinus rhythm and no electrocardiogram (EKG) changes were seen. Two-layer closure was performed. After completion of the valve insertion, the patient was placed in steep Trendelenburg, cross-clamp was removed and routine de-airing procedures were performed. Patient was weaned off CPB. See Table 2 for intraoperative bypass data.
The patient was discharged home on postoperative day 6. Repeat echocardiogram in two weeks showed mild AI, trace MR and mild TR. Thus, replacing the aortic valve also reduced the severity of the MR and TR.
Discussion
Sickle cell disease (SCD) and its variants are genetic disorders of mutant Hb. The most common form in North America is homozygous Hb S disease w1x. The degree of abnormality and quantity of sickle cell hemoglobin (Hb S) dictates the clinical severity of the disease. Sickle cell trait is a heterozygous (Hb AS) manifestation where the concentration of HbS is -50%, while SCD is a homozygous genotype (Hb SS) with the concentration of HbS varying from 70 to 98% w1x. Loss of red blood cell elasticity is central to the pathophysiology of SCD. In SCD, low-oxygen tensions promote red blood cell sickling and repeated episodes of sickling damage the cell membrane and decrease the cell's elasticity. These cells fail to return to normal shape when normal oxygen tension is restored, resulting in rigid blood cells that are unable to deform as they pass through narrow capillaries, leading to vessel occlusion and ischemia. Although the bone marrow attempts to compensate by creating new red cells, it does not match the rate of destruction. Healthy red blood cells typically live 90-120 days, but sickle cells only survive 10-20 days. It is well documented in the medical literature that low oxygen tension and acidosis can induce sickling of the red blood cells w2, 3x. The risk of intraoperative crisis due to SCD is a major consideration at cardiovascular surgery centers as CPB may trigger a crisis of profound magnitude, and being prepared is important. Classical precipitants that induce sickling are hypoxia, dehydration, acidosis, exposure to cold, stress, and intercurrent infections w4x. Use of CPB, low-flow states, aortic cross-clamping, topical hypothermia, and cold crystalloid cardioplegia may all predispose patients to sickling crisis during cardiac surgery w4x. One could postulate that even the local acidemia associated with intermittent cardioplegia or the minimal acidemia associated with continuous warm cardioplegia could induce sickling.
Apart from keeping the patient's venous saturation high, keeping the pH alkalotic and using warming blankets, we further reduced any risk of sickling with our novel surgical technique. Maintaining normothermia throughout the case potentially reduced the chance of a crisis. One concern we had was the higher flow rates needed for normothermic CPB may lead to more hemolysis and a greater transfusion requirement. This concern did not become evident in this case. By allowing the heart to continue beating we eliminated the use of cardioplegia while, at the same time, transfusion of warm blood via coronary ostia cannulation reduced the risk of ischemia.
In conclusion, allowing the heart to continue beating in a warm patient with SCD is a novel technique for aortic valve replacement. The technique is simple, and, in conjunction with the standard anesthesia and perfusion protocols in place for this group of patients, further reduces the risks of any intraoperative crises occurring. Usman et al.'s report brings into sharp focus some of the controversial issues regarding the management of cardiopulmonary bypass (CPB) in sickle cell disease (SCD) w1x. Our group w2x and others w3x have shown that CPB can be performed safely without exchange transfusion in SCD patients. The majority of cases of CPB in SCD (mostly sickle cell trait) have employed exchange transfusion to reduce the hemoglobin S fraction to -30% upon the assumption that such 'dilution' of hemoglobin S reduces perioperative complications attributable to SCD. However, there is a lack of definitive control data to validate this practice w4x.
In Ghana, SCD is present in 2% of newborns and the hemoglobin S gene is present in 20% of individuals. Our protocol for management of SCD patients undergoing CPB is derived from our experience with CPB in SCD. We reported successful mechanical mitral valve replacement in two patients both aged 12 years (hemoglobin SS) and tricuspid valve repair in a third patient aged 17 years (hemoglobin SC) in 2001 w5x. In all three patients, perioperative exchange transfusion was avoided. Our technique of CPB in SCD has been described w2, 5x. We employ aorto-bicaval cannulation and infuse cold crystalloid cardioplegia into the root of the cross-clamped aorta with systemic hypothermia (25-30 8C). The mean hematocrits during bypass for the three patients in our report were 15.2%, 15.4% and 22.0% w5x. Separation from CPB was accomplished uneventfully in all three patients; each patient received blood transfusion (2 units) as required to bring up the hematocrit close to 30%. We take meticulous care to avoid hypoxia, acidosis, hypotension and dehydration in these patients w2, 5x. Contrary to Usman's group w1x, we do not hesitate to use systemic hypothermia and cold crystalloid cardioplegic arrest. Hypothermia tends to retard sickling because of a leftward shift of the oxygen dissociation curve. In addition, thermoregulatory vasoconstriction, the presumed mechanism of hypothermia-induced sickling, would be impaired by the level of anesthesia needed for CPB w4x.
